South Africa, considered the country most affected by the human immunodeficiency virus (HIV), is preparing to launch a new treatment, more effective than the existing ones, the Health Minister announced today.
The TLD treatment, which will be launched on December 1, on the occasion of World AIDS Day, is considered by the South African authorities, cited by France-Presse, as "the fastest way to reduce viral load."
The treatment was presented today by South African Health Minister Zweli Mkhize in KwaZulu-Natal, the province of that country most affected by the virus.
TLD combines in one tablet three antiretroviral drugs: tenofovir disoproxil, lamivudine and dolutegravir.
The drug is financially supported by Unitaid, an international global health organization whose chief operating officer, Robert Matiru, said it was “a highly effective treatment” that allows “much faster virus suppression” than others. and causes “fewer side effects”.
Treatment is expected to be launched at an affordable price (about $ 75 per year per person) and will allow about five million infected people in South Africa to start or continue treatment.
In South Africa 7.7 million people live with HIV, 4.8 million of them receiving antiretroviral therapy.
The highest prevalence rate of the disease is in people aged 15 to 49 years.
According to Unitaid, 10% of AIDS deaths and 15% of new HIV infections worldwide occur in South Africa.
. (tagsToTranslate) south africa